Although we could not identify the specific DUB responsible for regulating Smad4 expression, our data suggest that inhibition of DUBs might be a candidate therapeutic treatment to reduce Smad4 expression and prevent renal fibrosis in CKD. Here, ZUP1 is linked to chronic kidney disease.